Want to join the conversation?
Specialty generic pharmaceutical company $AKRX reported higher 1Q16 results, helped in part by portfolio growth, and maintained its 2016 outlook. The company reported 1Q16 earnings of $42MM, or $0.34 per share, compared to $38MM, or $0.31 per share a year ago. Revenue rose 18% to $268MM.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!